The available database comprises research projects in Fisheries, Aquaculture, Seafood Processing and Marine Biotechnology active in the time period 2003-2022.
BlueBio is an ERA-NET COFUND created to directly identify new and improve existing ways of bringing bio-based products and services to the market and find new ways of creating value from in the blue bioeconomy.

More information on the BlueBio project and participating funding organizations is available on the BlueBio website: www.bluebioeconomy.eu

Last Update: 2024/06/19

DigiBiotics
Marine Biotechnology
Digital discovery of antimicrobial molecules from marine Arctic resources with reduced risk of triggering resistance
National Programme
National
John Sigurd Mjøen Svendsen
john-sigurd.svendsen@uit.no
UiT - The Arctic University of Norway (Norway)
NA - Amicoat AS (Norway)NA - AstraZeneca AB (Sweden)UOA - University of Aberdeen (United Kingdom)
2017
2023
€ 2,097,055
https://www.digitallifenorway.org/research/digibiotics/
The goal of DigiBiotics is to translate innovative scientific discoveries into commercially attractive propositions by combining in-depth scientific knowledge with a broad understanding of the requirements of successful drug discovery and development. This goal will be reached by fulfilling five scientific objectives and one training objective: • Digitally mine genomes, isolate and identify novel antimicrobial molecules from Arctic marine microorganisms with a selection of compounds less prone to trigger resistance development • Create, develop and validate experimental and computational methods for determination of molecular structure, absolute configuration and conformation. • Provide, through new computational and experimental methods, an in-depth understanding of structure-activity relationships for “middle-space molecules” enabling optimization of their biological activity • Compute quantitative structure activity relationships (QSAR) for knowledge-driven refinement of antimicrobial molecules into compounds with acceptable pharmacokinetics, optimizing potency, absorption, distribution and metabolic properties. • Define the microbial targets and resistance development to provide feedback for refined design. • Train young scientists in the cross-disciplinary skills needed for future successful drug discovery
Bioprospecting; Antimicrobials; Genetic; Human health; Drug discovery; Genomic;
Not associated to marine areas
map png
If there is any incorrect or missing information on this project please access here or contact bluebio.database@irbim.cnr.it
/* */